http://cuatrosentidos.es/wp-content/uploads/2010/03/crecimiento-3.jpg

$0

$100

$200

$300

$400

$500

$600

$700

Dic-02

Mar

-03

Jun-

03

Sep-0

3

Dic-03

Mar

-04

Jun-

04

Sep-0

4

Dic-04

Mar

-05

Jun-

05

Sep-0

5

Dic-05

Mar

-06

Jun-

06

Sep-0

6

Dic-06

Mar

-07

Jun-

07

Sep-0

7

Dic-07

Mar

-08

Jun-

08

Sep-0

8

Dic-08

Mar

-09

Jun-

09

Sep-0

9

Dic-09

Mar

-10

Jun-

10

Sep-1

0

Dic-10

Mar

-11

Annual average increase in sales of 0.2% ($ 26 mill. in 48 months)

Average annual increase in sales of 22% ($ 309 mill. in 51 months)

Millions of pesos

Market information. Mar 2010-February 2011. IMS.

The total market size increased 2.7% in values

Total pharmaceutical market indicators 2009 February 2011Evolution Index. Values 111 105Evolution Index. Units 100 102Annual sales position between laboratories (values) 39 38Annual sales position between laboratories (units) 58 55Part. Market (market share MS, values) 0.66% 0.71%Part. Market (market share MS, units) 0.34% 0.35%

Obesity market indicators Estimated annual Market value US $ 165 million MS of anorexigenic market VS total (value) 2.4% 1.8% MS Medix anorexigenic type (values) 19.4% 29.9%MS Medix anorexigenic type (units) 22.7% 41.1%

Dec-2009

Dic - 2009

Others

Feb-2011

Others

Others

OthersDec 2009

Feb 2011

1 Sanofi-aventis Asenlix - (1) 21.04%

2 Medix Obeclox - (2) 12.60% 3 Medix Redotex - (1) 11.69% 4 Liomont Redustat - (5) 11.56% 5 Pisa Lindeza - (6) 8.35%

6 Psicofarma Orlistat Gi Psi - (1) 6.76%

7 Roche Xenical - (3) 3.98% 8 Medix Esbelcaps - (1) 3.44% 9 Medix Neobes - (1) 3.22%

10 Medix Redotex N.f. - (1) 2.85%

11 Medix Esbeltex - (2) 2.04% 12 Medix Mz1 - (1) 2.03%

13 Inves Farmac Itravil - (1) 1.93%

14 Medix Solucaps - (1) 1.43%

Place Company Product Market share %

1 Sanofi-aventis Asenlix - (1) 46.29% 2 Medix Obeclox - (2) 12.84% 3 Liomont Redustat - (5) 9.16% 4 Medix Redotex - (1) 8.62% 5 Pisa Lindeza - (6) 4.64% 6 Roche Xenical - (3) 4.12% 7 Medix Esbelcaps - (1) 1.93% 8 Inves Farmac Itravil - (1) 1.85% 9 Medix Neobes - (1) 1.84%

10 Medix Redotex N.f. - (1) 1.84% 11 Psicofarma Orlistat Gi Psi - (1) 1.24% 12 Medix Esbeltex - (2) 0.92% 13 Medix Mz1 - (1) 0.77% 14 Medix Solucaps - (1) 0.63%

Place Company Product Market share %

Starting date of project development 2003Launch date: 2005Project months 93Accumulated total sales US$ 37,285,465Sales 2010 US$13,507,840

MAT Sep/10 7 Obeclox - (2) Medix $6,904,703 83.16%MAT Oct/10 10 Obeclox - (2) Medix $6,061,277 65.80%MAT Nov/10 11 Obeclox - (2) Medix $5,344,951 53.48%MAT Dic/10 16 Obeclox - (2) Medix $4,398,820 40.07%MAT Jan/11 22 Obeclox - (2) Medix $3,898,747 33.13%MAT Feb/11 15 Obeclox - (2) Medix $4,868,298 41.64%

% GrowthDate

Obeclox® position in the ethical market without milk in the products that provide higher volume to the growth

Rnk Product Laboratory Growth volume